Clinical Trials Logo

Clinical Trial Summary

To prospectively investigate the effect of transjugular intrahepatic portosystemic shunt (TIPS) on oxygenation in cirrhotic patients with hepatopulmonary syndrome (HPS).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02148536
Study type Observational
Source West China Hospital
Contact
Status Completed
Phase
Start date June 2014
Completion date September 2015

See also
  Status Clinical Trial Phase
Recruiting NCT01676597 - Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hepatopulmonary Syndrome N/A
Terminated NCT01518595 - Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis Phase 2
Completed NCT00362752 - A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome Phase 2
Active, not recruiting NCT03092401 - Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study N/A
Not yet recruiting NCT05373134 - Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome N/A
Terminated NCT02021929 - Sorafenib for Hepatopulmonary Syndrome Phase 2
Terminated NCT00593658 - Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome Phase 1
Recruiting NCT03435406 - Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western China N/A
Recruiting NCT04004104 - Supine Exercise in Hepatopulmonary Syndrome Patients With Orthodeoxia N/A
Recruiting NCT04577001 - Letrozole in Patients With Hepatopulmonary Syndrome Phase 2